Me, which helped popularize ancestry tracing through genetic testing, filed for bankruptcy protection and will seek a sale.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security ...

With Sunday’s announcement by genetic testing firm 23andMe that it has filed for bankruptcy, customers of the site may be wondering what will happen to their data and what, if anything ...

The once-popular genetic testing company has filed for bankruptcy after years of bad news, reigniting concerns about removing ...

Customers fear their data may be sold to a new company. Over the weekend, genetic testing and biotechnology company 23andMe filed for Chapter 11 bankruptcy. Founded in 2006, the company became ...

DNA testing service 23andMe filed for bankruptcy protection on March 16, sparking concerns about what could happen to the genetic data of the company’s 15 million customers. The company has said ...

"23andMe's bankruptcy announcement is concerning and I am urging New Yorkers to take action to safeguard their data," James said. "New Yorkers can follow instructions offered by my office to ...

23andMe, one of the "leading human genetics and biotechnology companies," announced that it has filed for bankruptcy. On Sunday, March 23, 23andMe Holding Co. announced it started voluntarily ...

23andMe filed for Chapter 11 bankruptcy and said it may be looking for a buyer. A bankruptcy filing by genetic testing and biotechnology company 23andMe and talks of a possible sale are shining a ...

The bankruptcy filing, and advice from state regulators that customers should withdraw their data from 23andMe, is almost certain to reduce that willingness. The company’s bankruptcy underscores ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San Francisco-based ...